Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BETRI: BDP/FF/GB vs BDP/FF in Asthma
NCT07666490Phase 4Recruiting
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jun 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 4 trial of glycopyrronium bromide in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started Jun 2026; status: recruiting.
02
Drugs
glycopyrronium bromide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07666490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07666490.